Email:   丨     Phone: +86-177-4907-8590
You are here: Home » News » Product News » SR9009 SARMS receptor optimizer introduction

SR9009 SARMS receptor optimizer introduction

Views:2     Author:Site Editor     Publish Time: 2021-10-06      Origin:Site

Fat loss is always followed by the introduction of SARMS SR9009. This product is also a product with strong fat reduction plasticity. It quickly breaks down fat, enhances heart rate performance, inhibits muscle breakdown and strengthens plasticity, and is safe without anti-female and liver protection. , No need to do PCT, no pressure on the stenabolic 9009 - Oasis

Advantages of stenabolic

Compared with GW50156, which is also fat-reducing, SR9009 focuses more on burning fat while reducing muscle loss.

As mentioned above, SR9009 has the ability to change the activity of skeletal muscle mitochondria, or simply, it can promote your metabolic activity. This makes it similar to DNP, SR9009 is safer and has no adverse effect on your endurance. In addition, unlike DNP, SR9009 has the ability to simulate actual aerobic exercise without actual adjustment. Therefore, it will improve your endurance, rather than hurt it.

Stenabolic (SR9009) binds to a protein called Rev ErBA, which is important because this protein affects the burning of fat and sugar in the liver, the production of fat cells, and the body's inflammatory response. Therefore, this interaction between SR9009 and ErrErBA can make your current workout group more effective. In fact, even sitting on your hips all day will not hinder your goals. All in all, the ultimate goal is to burn off the energy of what you eat, not to store it as fat, and SR does a great job. 

 SR9009 liquid will attack existing fat and burn it

Stenabolic (SR9009) can help a person become thinner, and it can help them do more aerobic exercise without feeling tired as before. In general, it will increase your VO2 maximum, allowing you to improve endurance.

In addition, SR9009 can also benefit non-athletes because it can reverse obesity, metabolic syndrome and type 2 diabetes.